Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9310004 | 1.00 | CYP2D6 (0.30) | CYP2D6 | |
| SCHEMBL30011441 | 1.00 | CYP2D6 (0.30) | CYP2D6 | |
| SCHEMBL11886110 | 1.00 | CYP2D6 (0.30) | CYP2D6 | |
| SCHEMBL1649438 | 1.00 | CYP2D6 (0.30) | CYP2D6 | |
| SCHEMBL12961198 | 0.77 | CYP2D6 (0.31) | CYP2D6 | |
| SCHEMBL14818249 | 0.77 | CYP2D6 (0.31) | CYP2D6 | |
| SCHEMBL13892950 | 0.77 | CYP2D6 (0.31) | CYP2D6 | |
| SCHEMBL13393749 | 0.77 | CA1 (0.32) | CYP2D6 | |
| SCHEMBL7906063 | 0.72 | — | — | |
| SCHEMBL19118462 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4380552-A1 | PROCESS FOR PREPARING PARTICLES COMPRISING AN ENCAPSULATED LIPID | Stabican B.V. (NL) | 2024-06-12 | — | — | EP | claimed |
| WO-2023287283-A1 | PROCESS FOR PREPARING PARTICLES COMPRISING AN ENCAPSULATED LIPID | STABICAN B.V. (NL) | 2023-01-19 | — | — | WO | claimed |
| EP-3236927-B1 | HAIR COMPOSITION | UNILEVER PLC (GB) | 2019-11-13 | — | — | EP | claimed |
| US-10456344-B2 | Hair composition | CONOPCO, INC. (US) | 2019-10-29 | — | — | US | claimed |
| US-20170360673-A1 | HAIR COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2017-12-21 | — | — | US | claimed |
| EP-3236927-A1 | HAIR COMPOSITION | Unilever PLC (GB) | 2017-11-01 | — | — | EP | claimed |
| CN-107106628-A | Hair composition | 荷兰联合利华有限公司 | 2017-08-29 | — | — | CN | claimed |
| US-20170006861-A1 | ANIMAL ATTRACTANT AND REPELLANT AND METHOD OF MAKING THE SAME | Great Lakes Cordage Company (US) | 2017-01-12 | — | — | US | claimed |
| WO-2016102177-A1 | HAIR COMPOSITION | UNILEVER PLC (GB) | 2016-06-30 | — | — | WO | claimed |
| EP-0666027-A1 | Method of repelling insects | COULSTON INTERNATIONAL CORPORATION (US) | 1995-08-09 | — | — | EP | claimed |
| EP-0450087-A1 | CAT ATTRACTANT APPLYING METHOD AND APPLICATOR | KOJIMA, Yujiro (JP) | 1991-10-09 | — | — | EP | claimed |
| WO-2026101300-A1 | FUNCTIONAL FEED COMPOSITION FOR SEDATIVE EFFECTS IN COMPANION ANIMALS AND METHOD FOR PRODUCING FEED USING SAME | 주식회사 호마드 | 2026-05-15 | — | — | WO | disclosed |
| US-12507699-B2 | Natural mosquito repellent composition and process of preparing the same | COROMANDEL INTERNATIONAL LTD. (IN) | 2025-12-30 | — | — | US | disclosed |
| EP-4380552-A1 | PROCESS FOR PREPARING PARTICLES COMPRISING AN ENCAPSULATED LIPID | Stabican B.V. (NL) | 2024-06-12 | — | — | EP | disclosed |
| US-20240074995-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FIRST WAVE BIO, INC. | 2024-03-07 | — | — | US | disclosed |
| US-4869896-A | N,N-DIETHL-M-TOLUAMIDE AND BICYCLIC LACTONE | ANGUS CHEMICAL COMPANY (US) | 1989-09-26 | — | — | US | disclosed |
| EP-0167266-B1 | INSECT REPELLENT COMPOSITION AND METHOD OF REPELLING INSECTS | ANGUS CHEMICAL COMPANY (US) | 1989-08-02 | — | — | EP | disclosed |
| US-4663346-A | Insect repellent | ANGUS CHEMICAL COMPANY (US) | 1987-05-05 | — | — | US | disclosed |
| EP-0167266-A1 | Insect repellent composition and method of repelling insects | ANGUS CHEMICAL COMPANY (US) | 1986-01-08 | — | — | EP | disclosed |
| EP-0167265-A1 | Method of repelling insects | COULSTON INTERNATIONAL CORPORATION (US) | 1986-01-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240074995-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FH, CS, ECHS1 | CYP2D6 953/4885 |
| US-12507699-B2 | Natural mosquito repellent composition and process of preparing the same | SGMS2, CETP, NEFM | CYP2D6 2293/4885 |
| US-10456344-B2 | Hair composition | GLS2, GLS, LHCGR | CYP2D6 634/4885 |
| US-20170360673-A1 | HAIR COMPOSITION | GLS2, GLS, CYP17A1 | CYP2D6 696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.